<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39259107</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>22</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Prolonged loss of intercostal muscle mass and its predictors in COVID-19 patients: A retrospective study from tertiary hospital.</ArticleTitle><Pagination><StartPage>e38284</StartPage><MedlinePgn>e38284</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e38284</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000038284</ELocationID><Abstract><AbstractText>Sarcopenia is a contributing factor in the development of long-COVID syndrome. We aimed to investigate how intercostal muscle mass changes over 3 months compared to other chest wall muscles following COVID-19 infection, along with identifying factors contributing to intercostal muscle loss during follow-up. We retrospectively studied 110 COVID-19 patients, analyzing muscle masses in the intercostal, pectoralis, and thoracic 12th vertebra level (T12) on initial and follow-up CT scans. Muscle mass was quantitatively assessed using density histogram analysis. We calculated the muscle difference ratio (MDR) as the following formula: (initial muscle mass - follow-up muscle mass)/initial muscle mass. Patients were categorized into 2 groups: &lt;3 months follow-up (n&#x2005;=&#x2005;53) and&#x2005;&#x2265;&#x2005;3 months follow-up (n&#x2005;=&#x2005;57). We employed stepwise logistic regression, using intercostal MDR&#x2005;&#x2265;&#x2005;25% in follow-up as an independent variable and age&#x2005;&lt;&#x2005;65 years, ventilator use, steroid use, follow-up&#x2005;&gt;&#x2005;3 months, hospital stay&#x2005;&gt;&#x2005;13 days, body mass index&#x2005;&lt;&#x2005;18.5&#x2009;kg/m&#xb2;, and female gender as dependent variables. The loss of intercostal muscle was the most severe among the 3 chest wall muscles in the CT follow-up. Intercostal MDR was significantly higher in the&#x2005;&#x2265;&#x2005;3 months follow-up group compared to the&#x2005;&lt;&#x2005;3 months group (32.5&#x2005;&#xb1;&#x2005;23.6% vs 19.0&#x2005;&#xb1;&#x2005;21.1%, P&#x2005;=&#x2005;.002). There were no significant differences in pectoralis MDR or T12 MDR between the 2 groups. Stepwise logistic regression identified steroid use (3.494 (1.419-8.604), P&#x2005;=&#x2005;.007) and a follow-up period&#x2005;&gt;&#x2005;3 months [3.006 (1.339-6.748), P&#x2005;=&#x2005;.008] as predictors of intercostal MDR&#x2005;&#x2265;&#x2005;25%. The intercostal muscle wasting was profound compared to that in the pectoralis and T12 skeletal muscles in a follow-up CT scan, and the intercostal muscle wasting was further aggravated after 3 months of COVID-19 infection. The use of steroids and a follow-up period exceeding 3 months were significant predictors for&#x2005;&#x2265;&#x2005;25% of intercostal muscle wasting in follow-up.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koo</LastName><ForeName>Byeong Ju</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Gyeongsang National University College of Medicine, Jinju, Gyeongsangnam-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Ho Cheol</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Department of Radiology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Gyeongsangnam-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Hye Young</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Medicine, Gyeongsang National University College of Medicine, Jinju, Gyeongsangnam-do, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Gyeongsangnam-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Hwa Seon</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Radiology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Gyeongsangnam-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Won</LastName><ForeName>Jung Ho</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Radiology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Gyeongsangnam-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Seok Jin</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Radiology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Gyeongsangnam-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Won Jeong</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Department of Radiology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Gyeongsangnam-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Jae Kyeong</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Radiology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Gyeongsangnam-do, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Mi Jung</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-1136-1763</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Gyeongsang National University College of Medicine, Jinju, Gyeongsangnam-do, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Gyeongsangnam-do, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007366" MajorTopicYN="Y">Intercostal Muscles</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055948" MajorTopicYN="Y">Sarcopenia</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="Y">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="Y">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>10</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39259107</ArticleId><ArticleId IdType="pmc">PMC11142803</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000038284</ArticleId><ArticleId IdType="pii">00005792-202405310-00055</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cesanelli L, Satkunskiene D, Bileviciute-Ljungar I, et al. . The possible impact of COVID-19 on respiratory muscles structure and functions: a literature review. Sustainability. 2022;14:7446.</Citation></Reference><Reference><Citation>Chandarana H, Pisuchpen N, Krieger R, et al. . Association of body composition parameters measured on CT with risk of hospitalization in patients with Covid-19. Eur J Radiol. 2021;145:110031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8592118</ArticleId><ArticleId IdType="pubmed">34801878</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraudo C, Librizzi G, Fichera G, et al. . Reduced muscle mass as predictor of intensive care unit hospitalization in COVID-19 patients. PLoS One. 2021;16:e0253433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8211180</ArticleId><ArticleId IdType="pubmed">34138945</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JW, Yoon JS, Kim EJ, et al. . Prognostic implication of baseline sarcopenia for length of hospital stay and survival in patients with coronavirus disease 2019. J Gerontol A Biol Sci Med Sci. 2021;76:e110&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083663</ArticleId><ArticleId IdType="pubmed">33780535</ArticleId></ArticleIdList></Reference><Reference><Citation>Surov A, Kardas H, Besutti G, et al. . Prognostic role of the pectoralis musculature in patients with COVID-19. A multicenter study. Acad Radiol. 2023;30:77&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9108033</ArticleId><ArticleId IdType="pubmed">35667979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ufuk F, Demirci M, Sagtas E, et al. . The prognostic value of pneumonia severity score and pectoralis muscle area on chest CT in adult COVID-19 patients. Eur J Radiol. 2020;131:109271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7480333</ArticleId><ArticleId IdType="pubmed">32942198</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo L, De Lorenzo R, D&#x2019;Amico M, et al. . COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: a post-hoc analysis of a prospective cohort study. Clin Nutr. 2021;40:2420&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598735</ArticleId><ArticleId IdType="pubmed">33160700</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowicz K, Gasowski J, Michel JP, et al. . Post-COVID-19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res. 2021;33:2887&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8323089</ArticleId><ArticleId IdType="pubmed">34328636</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Islas D, Sanchez-Moreno C, Orea-Tejeda A, et al. . Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections. BMC Pulm Med. 2022;22:223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9175169</ArticleId><ArticleId IdType="pubmed">35676657</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker MS, Landmesser U, von Haehling S, et al. . Weight loss, malnutrition, and cachexia in COVID-19: facts and numbers. J Cachexia Sarcopenia Muscle. 2021;12:9&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7890265</ArticleId><ArticleId IdType="pubmed">33382211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanza E, Muglia R, Bolengo I, et al. . Quantitative chest CT analysis in COVID-19 to predict the need for oxygenation support and intubation. Eur Radiol. 2020;30:6770&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7317888</ArticleId><ArticleId IdType="pubmed">32591888</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino S, Albano D, Cozzi A, et al. . CT-derived chest muscle metrics for outcome prediction in patients with COVID-19. Radiology. 2021;300:E328&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7971428</ArticleId><ArticleId IdType="pubmed">33724065</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MJ, Cho JM, Jeon KN, et al. . Mass and fat infiltration of intercostal muscles measured by CT histogram analysis and their correlations with COPD severity. Acad Radiol. 2014;21:711&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24809313</ArticleId></ArticleIdList></Reference><Reference><Citation>Finney LJ, Doughty R, Lovage S, et al. . Lung function deficits and symptom burden in survivors of COVID-19 requiring mechanical ventilation. Ann Am Thorac Soc. 2021;18:1740&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8522286</ArticleId><ArticleId IdType="pubmed">33769926</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa M, Nakajima M, Kaszynski RH, et al. . Abnormal pulmonary function and imaging studies in critical COVID-19 survivors at 100 days after the onset of symptoms. Respir Investig. 2021;59:614&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8185183</ArticleId><ArticleId IdType="pubmed">34148855</ArticleId></ArticleIdList></Reference><Reference><Citation>Farr E, Wolfe AR, Deshmukh S, et al. . Diaphragm dysfunction in severe COVID-19 as determined by neuromuscular ultrasound. Ann Clin Transl Neurol. 2021;8:1745&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8351384</ArticleId><ArticleId IdType="pubmed">34247452</ArticleId></ArticleIdList></Reference><Reference><Citation>Boussuges A, Habert P, Chaumet G, et al. . Diaphragm dysfunction after severe COVID-19: an ultrasound study. Front Med (Lausanne). 2022;9:949281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9448976</ArticleId><ArticleId IdType="pubmed">36091672</ArticleId></ArticleIdList></Reference><Reference><Citation>Moctezuma-Velazquez P, Miranda-Zazueta G, Ortiz-Brizuela E, et al. . Low thoracic skeletal muscle area is not associated with negative outcomes in patients with COVID-19. Am J Phys Med Rehabil. 2021;100:413&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">33587451</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gassel RJJ, Bels J, Remij L, et al. . Functional outcomes and their association with physical performance in mechanically ventilated coronavirus disease 2019 survivors at 3 months following hospital discharge: a cohort study. Crit Care Med. 2021;49:1726&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8439632</ArticleId><ArticleId IdType="pubmed">33967204</ArticleId></ArticleIdList></Reference><Reference><Citation>Hocaoglu E, Ors S, Yildiz O, et al. . Correlation of pectoralis muscle volume and density with severity of COVID-19 pneumonia in adults. Acad Radiol. 2021;28:166&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7704063</ArticleId><ArticleId IdType="pubmed">33281041</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung C, Wernly B, Fj&#xf8;lner J, et al. . Steroid use in elderly critically ill COVID-19 patients. Eur Respir J. 2021;58:2100979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8246007</ArticleId><ArticleId IdType="pubmed">34172464</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwahara M, Kamigaito M, Murakami H, et al. . Prognostic factors associated with mortality of patients with COVID-19 requiring ventilator management: a retrospective cohort study. Cureus. 2022;14:e25374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9236674</ArticleId><ArticleId IdType="pubmed">35774696</ArticleId></ArticleIdList></Reference><Reference><Citation>Ro S, Nishimura N, Imai R, et al. . Identification of patients with COVID-19 who are optimal for methylprednisolone pulse therapy. Multidiscip Respir Med. 2021;16:781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8273631</ArticleId><ArticleId IdType="pubmed">34322232</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao T, Kirk B, Phu S, et al. . Prevalence of sarcopenia and its association with antirheumatic drugs in middle-aged and older adults with rheumatoid arthritis: a systematic review and meta-analysis. Calcif Tissue Int. 2021;109:475&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">34132852</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada Y, Tada M, Mandai K, et al. . Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study. Clin Rheumatol. 2020;39:1757&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">31938882</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanada M, Ishimatsu Y, Sakamoto N, et al. . Corticosteroids are associated with reduced skeletal muscle function in interstitial lung disease patients with mild dyspnea. Respir Med. 2020;174:106184.</Citation><ArticleIdList><ArticleId IdType="pubmed">33086134</ArticleId></ArticleIdList></Reference><Reference><Citation>Kou HW, Yeh CH, Tsai HI, et al. . Sarcopenia is an effective predictor of difficult-to-wean and mortality among critically ill surgical patients. PLoS One. 2019;14:e0220699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6687130</ArticleId><ArticleId IdType="pubmed">31393937</ArticleId></ArticleIdList></Reference><Reference><Citation>Weijs PJ, Looijaard WG, Dekker IM, et al. . Low skeletal muscle area is a risk factor for mortality in mechanically ventilated critically ill patients. Crit Care. 2014;18:R12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4028783</ArticleId><ArticleId IdType="pubmed">24410863</ArticleId></ArticleIdList></Reference><Reference><Citation>Toledo DO, Carvalho AMRR, Oliveira AMRR, et al. . The use of computed tomography images as a prognostic marker in critically ill cancer patients. Clin Nutr ESPEN. 2018;25:114&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">29779805</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>